Advertisement

Topics

Teladoc Announces Full-Year and Fourth Quarter 2016 Results

16:01 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
2016 Revenue of $123.2 million, growth of 59%; 4Q 2016 Revenue of $37.4 million, growth of 65% Total Membership of 17.5 million, growth of 43% 2016 Visits of 952,081, growth of 65%; 4Q 2016 Visits of 310,467, ...

Other Sources for this Article

Teladoc, Inc.
Investors:
Jisoo Suh, 914-265-6706
Director of Investor Relations
jsuh@teladoc.com
or
Media:
Courtney McLeod, 203-253-3257
Director of Public Relations
cmcleod@teladoc.com

NEXT ARTICLE

More From BioPortfolio on "Teladoc Announces Full-Year and Fourth Quarter 2016 Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...